Loading...

We've got a brand new version of Simply Wall St! Try it out

Nutritional High International

CNSX:EAT
Snowflake Description

Weak fundamentals or lack of information.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EAT
CNSX
CA$52M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Nutritional High International Inc. focuses on manufacturing and distribution of cannabis oils, extracts, and edibles for medical and adult use purposes primarily in the United States and Canada. The last earnings update was 82 days ago. More info.


Add to Portfolio Compare Print
  • Nutritional High International has significant price volatility in the past 3 months.
EAT Share Price and Events
7 Day Returns
11.5%
CNSX:EAT
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-52.5%
CNSX:EAT
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
EAT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Nutritional High International (EAT) 11.5% -6.5% -19.4% -52.5% 123.1% -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • EAT underperformed the Pharmaceuticals industry which returned -46.7% over the past year.
  • EAT underperformed the Market in Canada which returned -0.1% over the past year.
Price Volatility
EAT
Industry
5yr Volatility vs Market

EAT Value

 Is Nutritional High International undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Nutritional High International is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nutritional High International has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Nutritional High International. This is due to cash flow or dividend data being unavailable. The share price is CA$0.145.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Nutritional High International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Nutritional High International's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:EAT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-04-30) in CAD CA$-0.06
CNSX:EAT Share Price ** CNSX (2019-09-20) in CAD CA$0.15
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Nutritional High International.

CNSX:EAT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:EAT Share Price ÷ EPS (both in CAD)

= 0.15 ÷ -0.06

-2.25x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nutritional High International is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Nutritional High International is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Nutritional High International's expected growth come at a high price?
Raw Data
CNSX:EAT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.25x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Nutritional High International, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Nutritional High International's assets?
Raw Data
CNSX:EAT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-04-30) in CAD CA$0.00
CNSX:EAT Share Price * CNSX (2019-09-20) in CAD CA$0.15
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:EAT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:EAT Share Price ÷ Book Value per Share (both in CAD)

= 0.15 ÷ 0.00

-146.46x

* Primary Listing of Nutritional High International.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nutritional High International has negative assets, we can't compare the value of its assets to the CA Pharmaceuticals industry average.

Next steps:

  1. Take a look at our analysis of EAT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Nutritional High International's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Pharmaceuticals industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Nutritional High International's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Nutritional High International has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EAT Future Performance

 How is Nutritional High International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nutritional High International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
97.7%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Nutritional High International expected to grow at an attractive rate?
  • Unable to compare Nutritional High International's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Nutritional High International's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Nutritional High International's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:EAT Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:EAT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:EAT Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-04-30 21 -8 -19
2019-01-31 18 -10 -12
2018-10-31 11 -7 -7
2018-07-31 6 -5 -10
2018-04-30 3 -7 -9
2018-01-31 0 -4 -8
2017-10-31 1 -3 -7
2017-07-31 1 -3 -5
2017-04-30 1 -1 -3
2017-01-31 1 -2 -2
2016-10-31 1 -1 -2
2016-07-31 1 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Nutritional High International is high growth as no earnings estimate data is available.
  • Unable to determine if Nutritional High International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:EAT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Nutritional High International Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EAT Past Financials Data
Date (Data in CAD Millions) EPS *
2019-04-30 -0.06
2019-01-31 -0.04
2018-10-31 -0.02
2018-07-31 -0.04
2018-04-30 -0.03
2018-01-31 -0.03
2017-10-31 -0.03
2017-07-31 -0.02
2017-04-30 -0.02
2017-01-31 -0.01
2016-10-31 -0.01
2016-07-31 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Nutritional High International will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of EAT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Nutritional High International's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Nutritional High International's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Nutritional High International's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Nutritional High International has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EAT Past Performance

  How has Nutritional High International performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Nutritional High International's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Nutritional High International does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Nutritional High International's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Nutritional High International's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Nutritional High International's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Nutritional High International Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:EAT Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-04-30 21.34 -19.14 16.94
2019-01-31 17.69 -11.72 13.57
2018-10-31 11.34 -6.87 9.08
2018-07-31 5.82 -9.71 6.29
2018-04-30 2.76 -8.74 4.20
2018-01-31 0.41 -7.95 3.84
2017-10-31 0.77 -6.73 3.29
2017-07-31 0.66 -5.01 3.54
2017-04-30 0.53 -3.24 3.29
2017-01-31 0.53 -2.28 2.49
2016-10-31 0.66 -2.02 2.44
2016-07-31 0.54 -2.31 1.90
2016-04-30 0.61 -1.97 2.11
2016-01-31 0.46 -1.99 2.18
2015-10-31 0.20 -1.89 2.04
2015-07-31 0.20 -2.06 2.09
2014-07-31 -2.72 1.30
2014-06-13 -1.75 1.75

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Nutritional High International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Nutritional High International has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Nutritional High International improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Nutritional High International's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Nutritional High International has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EAT Health

 How is Nutritional High International's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Nutritional High International's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Nutritional High International's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Nutritional High International's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Nutritional High International's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Nutritional High International has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Nutritional High International Company Filings, last reported 4 months ago.

CNSX:EAT Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-04-30 -0.33 8.35 2.24
2019-01-31 10.45 8.01 4.18
2018-10-31 12.39 8.23 7.48
2018-07-31 10.73 6.56 3.27
2018-04-30 7.90 6.43 7.76
2018-01-31 6.22 1.40 3.57
2017-10-31 4.49 1.42 1.18
2017-07-31 6.05 1.33 1.93
2017-04-30 8.40 1.08 2.61
2017-01-31 8.55 1.01 5.84
2016-10-31 3.61 0.71 1.50
2016-07-31 0.38 1.28 0.11
2016-04-30 1.32 1.18 0.42
2016-01-31 1.41 0.56 0.02
2015-10-31 0.92 0.37 0.10
2015-07-31 0.83 0.54 0.02
2014-07-31 0.48 0.00 0.62
2014-06-13 0.67 0.00 0.63
  • Nutritional High International has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Nutritional High International's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Nutritional High International has less than a year of cash runway based on current free cash flow.
  • Nutritional High International has less than a year of cash runway if free cash flow continues to grow at historical rates of 79.6% each year.
X
Financial health checks
We assess Nutritional High International's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Nutritional High International has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EAT Dividends

 What is Nutritional High International's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Nutritional High International dividends.
If you bought CA$2,000 of Nutritional High International shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Nutritional High International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Nutritional High International's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:EAT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Nutritional High International has not reported any payouts.
  • Unable to verify if Nutritional High International's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Nutritional High International's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Nutritional High International has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Nutritional High International's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Nutritional High International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Nutritional High International has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EAT Management

 What is the CEO of Nutritional High International's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Adam Szweras
COMPENSATION CA$0
AGE 47
TENURE AS CEO 0.3 years
CEO Bio

Mr. Adam Kelley Szweras, LLB serves as Secretary of Water Ways Technologies Inc. and has been its Director since December 2016. Mr. Szweras serves as Partner of Fogler, Rubinoff LLP, where he practices securities law and corporate law with a focus on cannabis related matters. Mr. Szweras serves as Corporate Secretary of Canada Pacific Capital Corp. and The Tinley Beverage Company Inc. He Co-Founded Nutritional High International Inc. He has been the Chief Executive Officer of Nutritional High International Inc. since June 2019. Mr. Szweras has been a Director of Nutritional High International Inc. since July 07, 2014 and served as its Co-Chairman since September 6, 2018 until June 2019. Mr. Szweras has been Corporate Secretary of Nutritional High International Inc. (formerly, Sonoma Capital Inc.) since July 07, 2014 and served as its Corporate Secretary until June 20, 2014. He has been Corporate Secretary at Lakeside Minerals Inc. since 2011. He has been Secretary of Sagittarius Capital Corporation since April 2014, Petrolympic Ltd., since June 17, 2008. He has been a Partner of Folger, Rubinoff LLP since 2006. He is an experienced securities lawyer and investment banking professional with an extensive background in corporate finance and cannabis-focused strategy development. His law practice focuses on financings and going public transactions. Mr. Szweras represents several mid-market public companies and assists companies in listing on the Toronto Stock Exchange and the TSX Venture Exchange. He also represents brokerage firms and has helped numerous clients with their financings and cross-border transactions. Mr. Szweras has a particular expertise with Capital Pool Company program and often acts as a strategic advisor to his clients. He co-founded Foundation Markets Inc. in January 2006 and serves as its Chairman. He founded FMI Capital Advisory Inc. (formerly known as Foundation Opportunities Inc.) in January 2006 and serves as its Chairman. He served as Corporate Secretary of Gunpowder Capital Corp. until January 2009. He served as Corporate Secretary of The Tinley Beverage Company Inc. until February 7, 2011. He served as Secretary at Academy Capital Corp. since September 12, 2005. He served as Secretary at Star Navigation Systems Group Ltd., from May 15, 2008 to June 2012. He served as a Secretary of Bassett Media Group Corp. Mr. Szweras was a Partner of Heenan Blaikie LLP from August 2004 to January 2006. From January 2002 to December 2002, he was a Partner of the securities law boutique, Carbonaro Sugar Szweras LLP (Formerly, Carbonaro Stewart Kligerman Sugar LLP) and from March 1999 to December 2001, he served as an Associate of Carbonaro Sugar Szweras LLP and Stewart and Associates LLP. He served as a Managing Partner of a Bay Street securities law boutique, where he represented public issuers and investment dealers. He served as a Corporate Secretary of Silver Shield Resources Corp. (alternative name Silver Shield Resources, Inc.) until January 2009. He has been a Director of Canada Pacific Capital Corp. since May 28, 2010. He has been Director of Quinsam Capital Corporation since October 19, 2017. He has been a Director of Harborside Inc., since May 2019. He has been Director of Aurora Cannabis Inc since August 10, 2015. He has been Independent Director at Sustainco Inc since March 03, 2017. Mr. Szweras has been a Director of Foundation Markets Inc. since November 2006, Sagittarius Capital Corporation since April 29, 2014. He served as a Director of Mahdia Gold Corporation since April 18, 2016 until March 2018. He served as Director of The Tinley Beverage Company Inc. from December 22, 2010 to September 29, 2016. He served as a Director at Sagittarius Capital Corporation from September 17, 2009 to August 31, 2010. He served as a Director of Koda Resources Ltd. He served as Director of Gunpowder Capital Corp. since December 2007 until January 2009. He served as a Director of Bassett Media Group Corp. until April 2010. He served as a Director of InterAmerican Gaming, Inc., from May 14, 2008 to July 30, 2009 and Academy Capital Corp., from August 2005 to November 2005. He served as a Director of Creso Exploration Inc. He served as a Director of Revival Gold Inc. from July 13, 2015 to December 7, 2015. He served as a Director of Silver Shield Resources, Inc. from December 2007 to January 2009. He served as a Director of Willowstar Capital Inc. from August 25, 2004 to November 2005. His legal practice and investment banking activities focus on corporate finance and going public transactions. From December 2001 to August 2004, he practiced law as an Associate with Fasken Martineau DuMoulin LLP. Since June 1997, Mr. Szweras practiced corporate and securities law with Burns Solicitors, as an Associate Lawyer. He has particular expertise in structuring cross-border and multi-jurisdictional securities transactions and mergers and acquisitions. He represents investment dealers and public issuers in undertaking RTOs and IPOs, develops tax effective structures for securities offerings and develops alternative asset class products. He served as an Editor of Canadian International Lawyer and the Canadian Bar Association Globetrotter. From January 1996 to June 1997, he acted as the media relations co-ordinator of the Consulate General of Israel in Toronto. He also assists in the establishment of mutual funds and pooled funds for public issuers and investments dealers. He successfully obtained 3 marijuana licenses in the USA. Mr. Szweras graduated with LL.B. from Osgoode Hall Law School, in 1994.

CEO Compensation
  • Adam's compensation has increased whilst company is loss making.
  • Adam's remuneration is lower than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Nutritional High International management team in years:

0.7
Average Tenure
47
Average Age
  • The average tenure for the Nutritional High International management team is less than 2 years, this suggests a new team.
Management Team

Adam Szweras

TITLE
Co-Founder
AGE
47
TENURE
0.3 yrs

Billy Morrison

TITLE
CTO & Director
COMPENSATION
CA$94K
AGE
41
TENURE
1.3 yrs

Jim Frazier

TITLE
Consultant
COMPENSATION
CA$101K
AGE
51
TENURE
0.3 yrs

Amy Lai Stephenson

TITLE
Consultant
COMPENSATION
CA$36K
AGE
60
TENURE
1.9 yrs

Michael DiNapoli

TITLE
Chief Financial Officer
TENURE
0.7 yrs

Ethan Karayannopoulos

TITLE
Director of Investor Relations

Alex Storcheus

TITLE
Senior Vice President of Corporate Development
AGE
29

Jeremy Pace

TITLE
Senior Vice President of Operations
TENURE
1 yrs

Sonia Agustina

TITLE
Strategic Advisor & Consultant
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure and age of the Nutritional High International board of directors in years:

3.3
Average Tenure
47.5
Average Age
  • The tenure for the Nutritional High International board of directors is about average.
Board of Directors

David Posner

TITLE
Chairman
COMPENSATION
CA$96K
AGE
45
TENURE
0.3 yrs

Adam Szweras

TITLE
Co-Founder
AGE
47
TENURE
5.2 yrs

Billy Morrison

TITLE
CTO & Director
COMPENSATION
CA$94K
AGE
41
TENURE
4.3 yrs

Brian Presement

TITLE
Independent Director
AGE
50
TENURE
5.9 yrs

Andres Tinajero

TITLE
Director
TENURE
2.4 yrs

Aaron Johnson

TITLE
Director
TENURE
1.6 yrs

David Caplan

TITLE
Member of Advisory Board
AGE
54
TENURE
1.6 yrs

Frank Galati

TITLE
Member of Advisory Board
TENURE
4.8 yrs

Debra Zwiefelhofer

TITLE
Member of Advisory Board
TENURE
4.8 yrs

Loreto Grimaldi

TITLE
Director
AGE
48
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
04. Jun 19 Buy 2222263 Ontario Inc. Company 29. May 19 29. May 19 500,000 CA$0.20 CA$100,000
29. May 19 Buy Adam Szweras Individual 29. May 19 29. May 19 490,000 CA$0.20 CA$98,000
X
Management checks
We assess Nutritional High International's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Nutritional High International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EAT News

Simply Wall St News

Did You Miss Nutritional High International's Whopping 575% Share Price Gain?

Nutritional High International isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. … Over the last three years Nutritional High International has grown its revenue at 115% annually. … It's always tempting to take profits after a share price gain like that, but high-growth companies like Nutritional High International can sometimes sustain strong growth for many years.

Simply Wall St -

EAT Company Info

Description

Nutritional High International Inc. focuses on manufacturing and distribution of cannabis oils, extracts, and edibles for medical and adult use purposes primarily in the United States and Canada. It offers cannabis-based vaping, concentrate, and infused edible products, such as vaporizer cartridges, cannabis oil syringes, and cannabis infused products that include chocolates, lozenges and mints, and others, as well as dab jars under the FLÏ brand name. The company also distributes other branded cannabis products. Nutritional High International Inc. was incorporated in 2004 and is based in Toronto, Canada.

Details
Name: Nutritional High International Inc.
EAT
Exchange: CNSX
Founded: 2004
CA$51,522,345
355,326,524
Website: http://www.nutritionalhigh.com
Address: Nutritional High International Inc.
77 King Street West,
Suite 2905,
Toronto,
Ontario, M5K 1H1,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX EAT Common Shares Canadian National Stock Exchange CA CAD 10. Apr 2015
OTCPK SPLI.F Common Shares Pink Sheets LLC US USD 10. Apr 2015
DB 2NU Common Shares Deutsche Boerse AG DE EUR 10. Apr 2015
Number of employees
Current staff
Staff numbers
0
Nutritional High International employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:29
End of day share price update: 2019/09/20 00:00
Last earnings filing: 2019/07/02
Last earnings reported: 2019/04/30
Last annual earnings reported: 2018/07/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.